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Abstract
Background: Normal findings of cardiac scintigraphy predict good outcomes. However, a paucity of the data exists
for elderly patients 85 years or older. In the present study, we aimed to demonstrate the association between the
abnormal findings of cardiac scintigraphy and the risk of all cause death in patients 85 years or older.
Methods: We enrolled 143 consecutive patients 85 years or older with known or suspected coronary artery disease
who underwent stress scintigraphy under adenosine or an exercise test and a 99mTechnetium (Tc)-labeled tracer or
thallium 201 (201Tl), dual tracer rest scintigraphy using 201Tl and 123I-β-methyl iodophenyl pentadecanoic acid (123I-
BMIPP), or 123I-BMIPP single tracer scintigraphy. Ischemia was defined by an induced perfusion abnormality
according to a provocation test with recovery at rest or decreased uptake of 123I-BMIPP despite normal perfusion at
rest. Infarction was defined by perfusion abnormalities assessed by images at rest on 201Tl or 99mTc-labeled tracer.
We defined these findings as abnormal when at least one of these aforementioned characteristics was observed.
Results: Patients in the abnormal findings group (N = 62) were more likely to have undergone prior coronary
angiography and to have decreased ejection fraction than those in the normal findings group (N = 81). The median
follow-up duration was 797 days (interquartile range, 635–1045 days), with follow-up rates of 90% at 1 year and 73%
at 2 years. The 2-year mortality rate were significantly higher in the abnormal findings group than in the normal
findings group (26.8% vs. 10.9%; p = 0.01). The risk of abnormal findings relative to normal findings remained
significant for the mortality (adjusted hazard ratio, 5.99; 95% CI, 1.37–42.8; P = 0.015).
Conclusion: Abnormal myocardial scintigraphy findings were associated with the increased risk for mortality, even
for patients 85 years or older.
Keywords: Abnormal, Finding, Elderly, Prognosis, Scintigraphy
Background
In developed countries, the population is aging [1]. It is
estimated that the prevalence of people 65 years or older
will triple from 2010 to 2050, and the oldest age group
(85 years or older) will account for up to 17% of the
elderly population [1]. However, in Japan, the oldest age
group already reached 15% in 2017. Furthermore, due to
the progress of medical therapies and revascularization
techniques, the life expectancy of patients with acute
coronary syndrome has improved [2]. Therefore, it is im-
portant to evaluate the ability of diagnostic testing to
convey meaningful information in this group of patients.
Although the significance of the normal myocardial
perfusion imaging for patients 75 years or older was
reported for those who were scheduled to undergo non-
cardiac surgery [3, 4], there is a paucity of data for
patients of more advanced age in Japan. In the present
study, we aimed to evaluate the prognostic value of
abnormal (or normal) scintigraphy findings for patients
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aged 85 years or older, which is a terminal age category
of current public health [5].
Methods
Study population
We retrospectively analyzed 143 consecutive patients
aged 85 years or older with known or suspected coron-
ary artery disease who underwent stress scintigraphy
under adenosine or an exercise test and 99mTechnetium
(Tc)-labeled tracer or thallium-201 (201Tl), dual tracer
rest scintigraphy using 201Tl and 123I-β-methyl iodophe-
nyl pentadecanoic acid (123I-BMIPP), or 123I-BMIPP
scintigraphy with normal electrocardiogram (ECG) re-
sults, at Kitano hospital from 2010 to 2013. We investi-
gated comorbidities, the presence of typical exertional
chest pain, and prior coronary angiography results, scin-
tigraphy findings, and outcomes from their medical
records. The study protocol conformed to the ethical
guidelines of the 1975 Declaration of Helsinki and was
approved by the institutional review board of Kitano
hospital. Informed consent was waived because this was
a retrospective study. We disclosed the details of the
present study to the public as an opt-out method and
the notice clearly informed patients of their right to
refuse enrollment. Follow-up data were collected by
reviewing hospital charts, by contacting the referring
physicians by mail, or by contacting the patients or
relative. When contacted for follow-up visit, no patients
refused to participate in the study viewing the opt-out
statement. Patient records and information were anon-
ymized prior to analysis.
Methods of nuclear imaging
Myocardial perfusion study using 99mTc-tetrofosmin, 99mTc-
sestamibi, or 201Tl
A myocardial perfusion study was conducted using 99mTc-
tetrofosmin or 99mTc-sestamibi with 259–300MBq for the
stress study and 740MBq for the rest study, or 201Tl with
111MBq [6]. The stress type was symptom-limited or >
85% of the maximum heart-rate exercise using a bicycle
ergometer (n = 8) and pharmacological administration of
adenosine (n = 88). A dual-headed single-photon emission
computed tomography (SPECT) system equipped with
low-energy collimators (Cannon Medical Systems Ltd.,
Tochigi, Japan) was used for data acquisition with a 360-
degree acquisition. ECG-Gated SPECT was performed
using a division of 16-frames per cardiac cycle at least at
rest. We reconstructed standard short-axis and long-axis
images using Butterworth and ramp filters, without scatter
correction or attenuation correction. Quantitative-gated
SPECT software was used to calculate left ventricular
functional parameters.
Metabolic imaging using 123I-BMIP
We used 148MBq of 123I-BMIPP. Myocardial perfusion
SPECT proceeded simultaneously using 111MBq of
201Tl (n = 16). With normal ECG findings, 123I-BMIPP
without perfusion imaging was used for diagnosis (n =
31) based on the discretion of attending physicians.
When using dual tracers, two separate 20% windows
were centered with one on the 123I photopeak (159
KeV). and the other on the 201Tl photopeak (75 KeV).
We did not apply cross-talk correction between 201Tl
and 123I-BMIPP.
Definitions
Ischemia was defined by an induced perfusion abnor-
mality according to a provocation test with recovery at
rest or decreased uptake of 123I-BMIPP despite normal
perfusion at rest or without information regarding perfu-
sion but with normal electrocardiogram results. Infarc-
tion was defined by perfusion abnormalities assessed by
images at rest on 201Tl or 99mTc-labeled tracer. We
defined findings as normal when none of these afore-
mentioned characteristics was observed. The defects
measurements were performed by experienced one radi-
ologist and one nuclear cardiologist. If one’s judgement
is different from the other’s, the final judgement has
been made after discussion. Ejection fraction according
to quantitative gating was obtained when available. The
presence or absence of comorbidities was based on the
assessment of the attending physicians. The diagnostic
modalities were selected based on the discretion of
attending physicians. The primary endpoints were all-
cause death. Every death was placed into one of the 2
categories: 1) cardiovascular deaths, which consist of
heart failure (HF), myocardial infarction, sudden death,
stroke, renal failure, aortic/peripheral vascular disease,
and other cardiac cause; and 2) non-cardiovascular
deaths, which include malignancy, infection, respiratory
failure, liver failure, renal failure, bleeding, and trauma,
and undetermined causes. Sudden death was defined as
unexplained death in a previously stable patient. Un-
determined cause of death was defined as non-sudden
death subsequent with severe illness with undetermined
etiology.
Availability of data
The datasets generated and analyzed during the
current study are not publicly available due to the pol-
icy of the institutional review board of our hospital,
but are available from the corresponding author on
reasonable request.
Statistical analysis
Categorical variables were expressed as numbers and
percentages. Continuous variables were expressed as
Kato et al. BMC Cardiovascular Disorders          (2019) 19:246 Page 2 of 7
means ± standard deviation (SD) or medians and inter-
quartile range (IQR). Based on their distributions, the
continuous variables were compared using the Stu-
dent’s t-test or the Wilcoxon rank sum test between
two groups.
The cumulative incidences of clinical events were es-
timated using the Kaplan-Meier method, and differ-
ences were assessed using the log-rank test.
Multivariable Cox proportional hazards models were
used to estimate the risk of abnormal findings relative
to normal findings of primary outcomes. The results
were expressed as hazard ratios (HRs) and 95% confi-
dence intervals (CIs). We selected clinically relevant
risk-adjusting variables (age 90 years or older, male,
the presence of chest pain, diabetes mellitus, atrial
fibrillation or flutter, and ejection fraction below 60%)
as the primary outcome measures. Sensitivity and
specificity for all-cause mortality using myocardial
scintigraphy were determined using the receiver-
operating characteristic (ROC) curve method after
classifying patients into four groups: grade 0 (normal
findings), group 1 (ischemia), group 2 (infarction), and
group 3 (ischemia plus infarction).
All statistical analyses were performed by two physi-
cians (T.K. and M.O.) using JMP 14 (SAS Institute Inc.,
Cary, NC). All probability values were two-tailed, and
the level of statistical significance was set at P < 0.05.
Results
Baseline clinical and imaging characteristics: normal
findings group versus abnormal findings group
Patients in the abnormal findings group were less likely
to be 90 years or older and more likely to have under-
gone coronary angiography and to have decreased ejec-
tion fraction at rest than those in the normal findings
Table 1 Patient characteristics and scintigraphy findings of the normal findings group versus the abnormal findings group
Normal findings (N = 62) Abnormal findings (N = 81) P value
Mean age, years (median and IQR) 88 [86–90] 86 [85–88] 0.029
Age 90 years or oldera, n (%) 18 (29) 10 (12) 0.018
Malea, n (%) 35 (56) 57 (70) 0.11
Chest paina, n (%) 17 (27) 27 (33) 0.47
Hypertension, n (%) 45 (72) 59 (72) 1.00
Dyslipidemia, n (%) 24 (38) 41 (50) 0.17
Diabetes mellitusa, n (%) 19 (30) 29 (35) 0.59
Current or past smoking, n (%) 13 (20) 25 (30) 0.25
Body mass index > 24, n (%) 10 (16) 14 (17) 1.00
Peripheral artery disease, n (%) 3 (4.8) 9 (11) 0.23
Dialysis, n (%) 0 (0) 3 (3.7) 0.25
Atrial fibrillation/fluttera, n (%) 19 (30) 28 (34) 0.72
Malignancy, n (%) 4 (6.4) 4 (4.9) 0.72
Prior coronary angiography, n (%) 13 (20) 36 (44) < 0.0001
Subsequent coronary angiography, n (%) 4 (6.4) 15 (18.2) < 0.0001
Scintigraphy
Adenosine provocation, n (%) 35 (56) 53 (65) 0.183
Exercise test, n (%) 4 (6) 4 (4)
201TL/123I-BMIPP, n (%) 10 (16) 6 (7)
123I-BMIPP, n (%) 13 (20) 18 (22)
Scintigraphy findings
Normal, n (%) 62 (100) 0 (0) < 0.0001
Ischemia, n (%) 0 (0) 36 (44)
Infarction, n (%) 0 (0) 37 (45)
Ischemia and infarction, n (%) 0 (0) 8 (9.8)
Ejection fraction at rest (mean ± SD) 73.8 ± 15.9 58.1 ± 25.4 0.011
Ejection fraction < 60%a 4 (6) 23 (28) 0.0009
201Tl Thallium 201, 123I-BMIPP 123I-β-methyl iodophenyl pentadecanoic acid
aPotential risk-adjusting variables selected for Cox proportional hazard models
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group (Table 1). Scintigraphy methods were not differ-
ent between the two groups.
Clinical outcomes: normal findings group versus
abnormal findings group
The median follow-up duration was 797 days (IQR, 635–
1045 days), with follow-up rates of 90% at 1 year and
73% at 2 years. The cumulative 2-year incidences of the
primary endpoints were significantly lower in the normal
findings group than in the abnormal findings group
(10.9% vs. 26.8%; p = 0.01) (Fig. 1). The unadjusted risk
of abnormal findings relative to normal findings was
2.46 (95%CI: 1.20–5.46: P = 0.013). After adjusting for
confounders, the risk of abnormal findings relative to
normal findings remained significant for the primary
outcome measure (HR, 5.99; 95% CI, 1.37–42.8; P =
0.015) (Table 2). Detailed information regarding the
cause of mortality is provided in Table 3. Sensitivity and
specificity for all-cause mortality using myocardial scin-
tigraphy indicated that when we classified patients into
four groups (grade 0, grade 1, grade 2, and grade 3), the
area under the ROC curve was 0.69 (Fig. 2).
Discussion
The main finding of the present study is that abnormal
SPECT findings were associated with increased risk for
patients 85 years or older with known or suspected cor-
onary artery disease.
The negative predictive value of normal myocardial
scintigraphy results was high in various prospective
studies [7, 8]. Matsuo et al. reported that normal scintig-
raphy results represented a lower cardiac risk [8]. How-
ever, more than half of patients enrolled in these studies
were younger than 70 years [7, 8], and patients 70 years
or older were at higher risk for cardiac events compared
Fig. 1 Kaplan-Meier curves of all-cause death
Table 2 Clinical outcome
Outcomes Normal findings
N of patients with event/N of
patients at risk (cumulative 2-year
incidence, %)
Abnormal findings
N of patients with event/N of












10/62 (10.9%) 24/81 (26.8%) 2.46 (1.20–5.46) 0.013 5.99
(1.37–42.8)
0.015
The number of patients with one event was counted through the entire follow-up period
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to those younger than 70 years [8]. The novel finding in
the present study is that, in the oldest patients in Japan,
abnormal SPECT findings were still associated with in-
creased risk and vice versa.
The prognostic value of SPECT has been evaluated in
several studies to determine its ability to indicate ab-
normal findings that predict survival for elderly patients
[8–12], and it was clearly reviewed by Patel et al. [13].
These studies comprised patients 70 years or older, 75
years or older, and 80 years or older, but not stratified by
85 years or older. Consistent with our data, the proportion
who underwent stress imaging, especially exercise stress
imaging, decreased with age [13]. Although coronary
intervention has been shown to improve the survival of
older patients with acute coronary syndromes [14], the
trade-off between the risks and benefits was considered
when making decisions regarding stable patients. Our data
may provide useful information regarding the prognostic
value of normal/abnormal findings of SPECT in patients
aged 85 years or more, a terminal age category in public
health, in Japan. This was consistent with the results of re-
ports using positron emission tomographic imaging for
patients 85 years or older in US and Europe [15]. Al-
though further large-scale studies are required to provide
stronger evidence, these findings will help practicing clini-
cians to make a diagnosis and treatment in the rapidly
aging population in Japan.
We did not analyze the cardiovascular (CV) and non-
CV death separately. Since the cause of death could not
be clearly distinguished and the trends of normal and
abnormal findings across the CV and non-CV death
were consistent, we only analyzed the association of all
cause death with scintigraphy findings. Non-cardiac
causes of death are increasing in causes of death in older
Table 3 Causes of death
Normal finding (N = 62) Abnormal finding (N = 81)
All-cause death 9 (14.5%) 24 (29.6%)
CV death 2 (3.2%) 10 (12.3%)
Sudden death 1, HF 1 Sudden death 3, HF 3, Vascular death 4
Non-CV death 5 (8.0%) 14 (17.2%)
Cancer 1, Infection 4 Cancer 3, Infection 9, Renal failure 2
Undetermined 2 (3.2%) 0 (0%)
CV Cardiovascular, HF Heart failure
Fig. 2 The ROC curves. Sensitivity and specificity for all-cause mortality using myocardial scintigraphy indicated that when we classified patients
into four groups (grade 0: normal findings, grade 1: ischemia, grade 2: infarction, and grade 3: ischemia plus infarction), the area under the ROC
curve was 0.69
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patients with CV disease [16–18]. An endpoint of the all
cause-death may be reasonable considering the oldest
patients with suspected or known CAD, as well as the
those with heart failure [19]. In the present study,
SPECT findings were still associated with all-cause death
in oldest population, consistently with other reports in
Japanese younger population [20].
There were several limitations to the present study.
The main limitation of the present study was its retro-
spective design; therefore, selection bias may have
occurred. Due to the retrospective fashion, there were
no prespecified criteria for scintigraphy indications for
patients with known or suspected coronary artery dis-
ease. Decisions regarding the use or non-use of diagnos-
tic imaging and the type of diagnostic imaging used
were based on the discretion of the physician. However,
the physicians were experienced cardiologists who gen-
erally performed all procedures according to the guide-
lines for diagnosis and management of coronary artery
disease. In addition, this is a single center study and
there may be a classification bias about the modality
selection for ischemic heart disease. Second, the tracer
in the present study consisted of perfusion tracers and a
metabolic tracer. Although a metabolic tracer is useful
for detecting ischemia [21–23], we did not evaluate these
modalities separately due to the small number of pa-
tients and events analyzed, the statistical power was lim-
ited. Third, we selected limited covariates for adjustment
based on clinical relevance and avoidance of multi-
collinearity. We have acknowledged that dyslipidemia,
smoking, alcohol, diet, body mass index, and hyperten-
sion may have prognostic impacts [24, 25]; however,
there was only solid evidence indicating that diabetes
had a prognostic impact on patients 85 years or older
[26]. Therefore, we included diabetes in the analysis. We
did not include previous coronary angiography because
it would have shown multi-collinearity with abnormal
scintigraphy findings. Finally, due to the old age and lim-
ited numbers of individuals in the populations analyzed,
the follow-up rate was relatively low despite the intensive
effort. There might be some subjects who died in other
hospitals, as a result we might overlook some of deaths.
Conclusion
Abnormal myocardial scintigraphy findings were asso-
ciated with increased risk, even for patients 85 years
or older.
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